In addition, there are difficulties with PSA assays in combination with DRE in the distinction of aggressive versus indolent prostate cancer although it has been reported that the level of the baseline PSA correlates with the development of worse prognosis prostate cancer.24 This evidence concerns the gene KLK3 and prostate carcinoma.